又一聚乳酸材料企业完成近亿元融资

Core Insights - Shanghai Jinghai Weixiang Biotech Co., Ltd. has successfully completed nearly 100 million RMB in Series B financing, exclusively funded by Jiazhi Fund, and is preparing for Series B+ financing [1] - The company focuses on "AI + synthetic biology + bio-based materials" and has established a closed-loop innovation model since its inception in 2020, creating a full industry chain layout from non-food biomass to product recycling [1][3] Company Overview - Jinghai Weixiang is recognized as a national high-tech enterprise and a specialized and innovative enterprise in Shanghai, emphasizing green and low-carbon production through advanced biomanufacturing technologies [1] - The company has developed several internationally leading production technologies for bio-based materials, including breakthroughs in non-food biomass utilization and new generation industrial strains [3] Technology and Products - Key technologies include gypsum-free lactic acid production, which addresses environmental pollution from traditional methods, and rPLA recycling, which enables the closed-loop lifecycle of polylactic acid (PLA) products [3] - PLA, the company's core product, is a high-performance biodegradable material with applications across various sectors, including fast-moving consumer goods, food and beverage, agriculture, 3D printing, textiles, biomedicine, and high-end manufacturing [3] Financing and Growth Plans - The funds from the recent financing round will be primarily used for expanding the production capacity of the company's scale-up base, developing next-generation technologies, and expanding market channels [4] - The company has achieved significant milestones in the industrialization of bio-based materials, with steady increases in production capacity and market share, and this financing will accelerate its growth and solidify its industry-leading position [4]